CC-4066

N/A

Report date: 2024/09/19 09:46:21
NME

Base Information

Drug NameCC-4066
Drug Alias NameCC-4066
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCyclophilins inhibitorsCyclophilin D inhibitors
TargetsCyclophilin DCyclophilins
Therapy Area/IndicationsDelayed Graft FunctionPancreatitis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited Kingdom
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesCypralis Ltd
China Registration ClassN/A

Develop Information

Active CompaniesCypralis Ltd
Inactive CompaniesN/A
Active IndicationsDelayed Graft FunctionPancreatitis
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A